Ballard, Clive
University of Exeter
80 papers on CoChatORCID 0000-0003-0022-5632
Most cited papers
- Verified
Neuroleptic drugs in dementia: benefits and harm
Ballard, C., & Howard, R. (2006) · Nature Reviews Neuroscience
Dementia and Cognitive Impairment ResearchSchizophrenia research and treatment
Cited by 308
- Verified
Towards defining the neuropathological substrates of vascular dementia
Kalaria, R. N., Kenny, R. A., Ballard, C. G., Perry, R., Ince, P., & Polvikoski, T. (2004) · Journal of the Neurological Sciences
Dementia and Cognitive Impairment ResearchNeurological Disease Mechanisms and Treatments
Cited by 291
- Verified
Impact of person-centred care training and person-centred activities on quality of life, agitation, and antipsychotic use in people with dementia living in nursing homes: a cluster-randomised controlled trial
Ballard, C., Corbett, A., Orrell, M., Williams, G., Moniz-Cook, E., Romeo, R., Woods, B., Garrod, L., Testad, I., Woodward-Carlton, B., et al. (2018) · PLOS Medicine
Dementia and Cognitive Impairment ResearchGeriatric Care and Nursing Homes
Cited by 263
- Verified
Anxiety, depression and psychosis in vascular dementia: prevalence and associations
Ballard, C., Neill, D., O’Brien, J., McKeith, I. G., Ince, P., & Perry, R. (2000) · Journal of Affective Disorders
Dementia and Cognitive Impairment ResearchNeurological Disease Mechanisms and Treatments
Cited by 257
- Verified
Use of drugs with anticholinergic effect and impact on cognition in Parkinson's disease: a cohort study
Ehrt, U., Broich, K., Larsen, J. P., Ballard, C., & Aarsland, D. (2010) · Journal of Neurology, Neurosurgery & Psychiatry
Parkinson's Disease Mechanisms and TreatmentsPharmaceutical Practices and Patient Outcomes
Cited by 254
- Verified
Memantine for Agitation/Aggression and Psychosis in Moderately Severe to Severe Alzheimer's Disease: A Pooled Analysis of 3 Studies
Wilcock, G. K., Ballard, C. G., Cooper, J. A., & Loft, H. (2008) · The Journal of Clinical Psychiatry
Dementia and Cognitive Impairment ResearchAlzheimer's disease research and treatments
Cited by 253
- Verified
Hypertension is a potential risk factor for vascular dementia: systematic review
Sharp, S. I., Aarsland, D., Day, S., Sønnesyn, H., Alzheimer's Society Vascular Dementia Systematic Review Group, & Ballard, C. (2011) · International Journal of Geriatric Psychiatry
Dementia and Cognitive Impairment ResearchNeurological Disease Mechanisms and Treatments
Cited by 241
- Verified
Management of behavioral and psychological symptoms in people with Alzheimer's disease: an international Delphi consensus
Kales, H. C., Lyketsos, C. G., Miller, E. M., & Ballard, C. (2019) · International Psychogeriatrics
Dementia and Cognitive Impairment ResearchAlzheimer's disease research and treatments
Cited by 220
- Verified
Synaptic markers of cognitive decline in neurodegenerative diseases: a proteomic approach
Bereczki, E., Branca, R. M., Francis, P. T., Pereira, J. B., Baek, J.-H., Hortobágyi, T., Winblad, B., Ballard, C., Lehtiö, J., & Aarsland, D. (2018) · Brain
Dementia and Cognitive Impairment ResearchAlzheimer's disease research and treatments
Cited by 220
- Verified
Tip of the Iceberg: Assessing the Global Socioeconomic Costs of Alzheimer’s Disease and Related Dementias and Strategic Implications for Stakeholders
El-Hayek, Y. H., Wiley, R. E., Khoury, C. P., Daya, R. P., Ballard, C., Evans, A. R., Karran, M., Molinuevo, J. L., Norton, M., & Atri, A. (2019) · Journal of Alzheimer's Disease
Dementia and Cognitive Impairment ResearchHealth Systems, Economic Evaluations, Quality of Life
Cited by 216
- Verified
Progressive brain atrophy on serial MRI in dementia with Lewy bodies, AD, and vascular dementia
O’Brien, J. T., Paling, S., Barber, R., Williams, E. D., Ballard, C., McKeith, I. G., Gholkar, A., Crum, W. R., Rossor, M. N., & Fox, N. C. (2001) · Neurology
Dementia and Cognitive Impairment ResearchNeurological Disease Mechanisms and Treatments
Cited by 215
- Verified
Medial temporal lobe atrophy on MRI in dementia with Lewy bodies
Barber, R., Gholkar, A., Scheltens, P., Ballard, C., McKeith, I. G., & O’Brien, J. T. (1999) · Neurology
Dementia and Cognitive Impairment ResearchParkinson's Disease Mechanisms and Treatments
Cited by 210
- Verified
Treatment with glucagon-like peptide-1 receptor agonists and incidence of dementia: data from pooled double-blind randomized controlled trials and nationwide disease and prescription registers.
Nørgaard, C. H., Friedrich, S., Hansen, C. T., Gerds, T., Ballard, C., Møller, D. V., Knudsen, L. B., Kvist, K., Zinman, B., Holm, E., et al. (2022) · Alzheimer's & Dementia: Translational Research & Clinical Interventions
Diabetes Treatment and ManagementDementia and Cognitive Impairment Research
Cited by 206
- Verified
Functional cognitive disorder: dementia’s blind spot
Ball, H. A., McWhirter, L., Ballard, C., Bhome, R., Blackburn, D. J., Edwards, M. J., Fleming, S. M., Fox, N. C., Howard, R., Huntley, J., et al. (2020) · Brain
Psychosomatic Disorders and Their TreatmentsDementia and Cognitive Impairment Research
Cited by 203
- Verified
Drug repositioning and repurposing for Alzheimer disease
Ballard, C., Aarsland, D., Cummings, J., O’Brien, J., Mills, R., Molinuevo, J. L., Fladby, T., Williams, G., Doherty, P., Corbett, A., et al. (2020) · Nature Reviews Neurology
Alzheimer's disease research and treatmentsDementia and Cognitive Impairment Research
Cited by 201
- Verified
Is physical activity a potential preventive factor for vascular dementia? A systematic review
Aarsland, D., Sardahaee, F. S., Anderssen, S., Ballard, C., & the Alzheimer's Society Systematic Review group (2010) · Aging & Mental Health
Dementia and Cognitive Impairment ResearchPhysical Activity and Health
Cited by 195
- Verified
Minocycline at 2 Different Dosages vs Placebo for Patients With Mild Alzheimer Disease: A Randomized Clinical Trial
Howard, R., Zubko, O., Bradley, R., Harper, E., Pank, L., O’Brien, J., Fox, C., Tabet, N., Livingston, G., Bentham, P., et al. (2020) · JAMA Neurology
Alzheimer's disease research and treatmentsDementia and Cognitive Impairment Research
Cited by 194
- Verified
Psychosis in Alzheimer disease—mechanisms, genetics and therapeutic opportunities
Ismail, Z., Creese, B., Aarsland, D., Kales, H. C., Lyketsos, C. G., Sweet, R. A., & Ballard, C. (2022) · Nature Reviews Neurology
Dementia and Cognitive Impairment ResearchAlzheimer's disease research and treatments
Cited by 189
- Verified
Determining the minimum clinically important differences for outcomes in the DOMINO trial
Howard, R., Phillips, P., Johnson, T., O'Brien, J., Sheehan, B., Lindesay, J., Bentham, P., Burns, A., Ballard, C., Holmes, C., et al. (2011) · International Journal of Geriatric Psychiatry
Dementia and Cognitive Impairment ResearchStatistical Methods in Clinical Trials
Cited by 185
- Verified
The Pattern of Cognitive Performance in CADASIL: A Monogenic Condition Leading to Subcortical Ischemic Vascular Dementia
Peters, N., Opherk, C., Danek, A., Ballard, C., Herzog, J., & Dichgans, M. (2005) · American Journal of Psychiatry
Cerebrovascular and genetic disordersNeurological Disease Mechanisms and Treatments
Cited by 178
- Verified
Efficacy of Memantine for Agitation in Alzheimer’s Dementia: A Randomised Double-Blind Placebo Controlled Trial
Fox, C., Crugel, M., Maidment, I., Auestad, B. H., Coulton, S., Treloar, A., Ballard, C., Boustani, M., Katona, C., & Livingston, G. (2012) · PLoS ONE
Dementia and Cognitive Impairment ResearchAlzheimer's disease research and treatments
Cited by 173
- Verified
Synaptic proteins predict cognitive decline in Alzheimer's disease and Lewy body dementia
Bereczki, E., Francis, P. T., Howlett, D., Pereira, J. B., Höglund, K., Bogstedt, A., Cedazo‐Minguez, A., Baek, J., Hortobágyi, T., Attems, J., et al. (2016) · Alzheimer's & Dementia
Dementia and Cognitive Impairment ResearchAlzheimer's disease research and treatments
Cited by 167
- Verified
Neuropsychological characteristics of mild vascular cognitive impairment and dementia after stroke
Stephens, S., Kenny, R. A., Rowan, E., Allan, L., Kalaria, R. N., Bradbury, M., & Ballard, C. G. (2004) · International Journal of Geriatric Psychiatry
Dementia and Cognitive Impairment ResearchNeurological Disease Mechanisms and Treatments
Cited by 165
- Verified
A Double-Blind Placebo-Controlled Randomized Trial of Melissa officinalis Oil and Donepezil for the Treatment of Agitation in Alzheimer’s Disease
Burns, A., Perry, E., Holmes, C., Francis, P., Morris, J., Howes, M.-J. R., Chazot, P., Lees, G., & Ballard, C. (2011) · Dementia and Geriatric Cognitive Disorders
Dementia and Cognitive Impairment ResearchAlzheimer's disease research and treatments
Cited by 149
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free